Antibody cross-reactivity induced by the homologous regions in glutamic acid decarboxylase (GAD65) and 2C protein of coxsackievirus B4

Clinical and Experimental Immunology

Volumn 104, Issue 3, 1996, Pages 398-405

  Lonnrot M ^a   Hyoty H ^a   Knip, M ^b   Roivainen, M ^c   Kulmala, P ^b   Leinikki, P ^c   Akerblom H K ^a,c  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b UNIVERSITY OF OULU   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Coxsackievirus B4; Cross reactivity; Glutamic acid decarboxylase; Insulin dependent diabetes mellitus; Synthetic peptides

Indexed keywords

AUTOANTIBODY; EPITOPE; GLUTAMATE DECARBOXYLASE; SYNTHETIC PEPTIDE;

AMINO ACID SEQUENCE; ARTICLE; CHILD; COXSACKIE VIRUS B4; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOFLUORESCENCE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANTIBODIES, BLOCKING; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; AUTOANTIBODIES; CARRIER PROTEINS; CASE-CONTROL STUDIES; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; CROSS REACTIONS; DIABETES MELLITUS, TYPE 1; ENTEROVIRUS B, HUMAN; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; FEMALE; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GLUTAMATE DECARBOXYLASE; HUMANS; INFANT; MALE; MOLECULAR SEQUENCE DATA; PEPTIDES; PRECIPITIN TESTS; VIRAL NONSTRUCTURAL PROTEINS;

EID: 0030022909     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.60771.x     Document Type: Article

References (40)

1. Baekkeskov S, Nielsen JH, Marner B et al. Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Nature (Lond) 1982; 298:167-9.
2. Baekkeskov S, Landin M, Kristensen K et al. Antibodies to a 64,000 Mr human islet cell antigen precede the clinical onset of insulin-dependent diabetes. J Clin Invest 1987; 79:926-34.
3. Atkinson MA, Maclaren NK, Scharp DW et al. 64,000 Mr autoantibodies as predictors of insulin-dependent diabetes. Lancet 1990; 335:1357-60.
4. Harrison LC, Honeyman MC, Deaizpura HJ et al. Inverse relation between humoral and cellular immunity to glutamine acid decarboxylase in subjects at risk of insulin-dependent diabetes. Lancet 1993; 341:1365-9.
5. Honeyman MC, Cram DS, Harrison LC. Glutumic acid decarboxylase 67-reactive T cells: a marker of insulin-dependent diabetes. J Exp Med 1993; 177:535-40.
6. Tisch R, Yang XD, Singer SM et al. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 1993; 366:72-75.
7. Parkkonen P, Hyöty H, Koskinen L, Leinikki P. Mumps virus infects beta cells in human fetal islet cell cultures upregulating the expression of HLA class 1 molecules. Diabetologia 1992; 35:63-69.
8. Yoon JW, London WT, Curfman BL et al. Coxsackie B4 virus produces transient diabetes in nonhuman primates. Diabetes 1985; 35:712-6.
9. Yoon JW. The role of viruses and environmental factors in the induction of diabetes. Curr Top Microbiol Immunol 1990; 164:95-123.
10. Szopa TM, Titchener PA, Portwood ND, Taylor KW. Diabetes mellitus due to viruses - some recent developments. Diabetologia 1993; 36:687-95.
11. Gamble DR, Taylor KW, Cumming H. Coxsackie viruses and diabetes mellitus. Br Med J 1973; 4:260-2.
12. Barrett-Connor E. Is insulin dependent diabetes mellitus caused by Coxsackie B infection? A review of the epidemiologic evidence. Ref Inf Dis 1985; 7:207-15.
13. Banatvala JE. Insulin dependent (juvenile-onset, type 1) diabetes mellitus. Coxsackie B viruses revisited. Prog Med Virol 1987; 34:33-54.
14. Frisk G, Friman G, Tuvemo T et al. Coxsackie B virus specific IgM in children at onset of type 1 (insulin-dependent) diabetes mellitus: evidence for IgM induction by a recent or current infection. Diabetologia 1992; 35:249-53.
15. Clements GB, Galbraith DN, Taylor KW. Coxsackie B virus infection and onset of childhood diabetes. Lancet 1995; 346:221-3.
16. Hyöty H, Hiltunen M, Knip M et al. A prospective study of the role of Coxsackie B and other enterovirus infections in the pathogenesis of insulin dependent diabetes mellitus. Diabetes 1995; 44:652-7.
17. Dahlquist GG, Ivarsson S, Lindberg B, Forsgren M. Maternal enteroviral infection during pregnancy as a risk factor for childhood IDDM: a population-based case-control study. Diabetes 1995; 44:408-13.
18. Kaufman DL, Erlander MG, Clare-Salzer M et al. Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J Clin Invest 1992; 89:283-92.
19. Kaufman DL, Clare-Salzler M, Tian J et al. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 1993; 366:69-72.
20. Atkinson MA, Bowman MA, Campbell L et al. Cellular immunity to a determinant common to glutamate decarboxylase and Coxsackie virus in insulin-dependent diabetes. J Clin Invest 1994; 94:2125-9.
21. Hou J, Said C, Franchi D et al. Antibodies to glutamic acid decarboxylase and P2-C peptides in sera from coxsackie virus B4-infected mice and IDDM patients. Diabetes 1994; 43:1260-6.
22. Richter W, Mertens T, Dchoel B et al. Sequence homology of the diabetes-associated autoantigen glutamate decarboxylase with coxsackie B4-2C protein and heat shock protein 60 mediates no molecular mimicry of autoantibodies. J Exp Med 1994; 180:721-6.
23. Tuomilehto J, Lounamaa R, Tuomilehto-Wolf E et al. Epidemiology of childhood diabetes in Finland - background of a nationwide study of Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1992; 35:70-76.
24. Hiltunen M, Hyöty H, Karjalainen J et al. Serological evaluation of the role of cytomegalovirus in the pathogenesis of IDDM: a prospective study. Diabetologia 1995; 38:705-10.
25. Knip M, Vähäsalo P, Karjalainen J et al. Natural history of preclinical IDDM in high risk siblings. Diabetologia 1994; 37:388-9.
26. King DS, Fields CG, Fields GB. A cleavage method which minimizes side reactions following Fmoc phase peptide synthesis. Int J Pep Prot Res 1990; 36:225-68.
27. Muller S. Peptide carrier conjugation. In: Burdon RH, Van-Knippenberg PH, eds. Laboratory techniques in biochemistry and molecular biology, 2nd edn. Amsterdam: Elsevier, 1990; 19: 95-144.
28. Parkkonen P, Hyöty H, Ilonen J et al. Antibody reactivity to an Epstein-Barr virus BERF4-encoded epitope occurring also in Asp-57 region of HLA-DQ8 beta chain. Clin Exp Immunol 1994; 95:287-93.
29. Roivainen M, Agboatwalla M, Stenvik M et al. Intrathecal immune response with virus-specific IgM antibodies in laboratory diagnosis of acute poliomyelitis. J Clin Microbiol 1993; 11:2427-32.
30. Roivainen M, Närvänen A, Korkolainen M et al. Antigenic regions of poliovirus type 3/Sabin capsid proteins recognized by human sera in the peptide scanning technique. Virology 1991; 180:99-107.
31. Hovi T, Roivainen M. Peptide antisera targeted to a conserved sequence in poliovirus capsid protein VPI cross-react widely with members of the genus enterovirus. J Clin Microbiol 1993; 31:1083-7.
32. Baekkeskov S, Aanstoot H-J, Christgau S et al. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 1990; 347:151-6.
33. Petersen JS, Hejnaes KR, Moody A et al. Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes 1994; 43:459-67.
34. Hagopian WA, Michelsen B, Karlsen AE et al. Autoantibodies in IDDM primarily recognize the 65,000-Mr rather than the 67,000-Mr isoform of glutamic acid decarboxylase. Diabetes 1993; 42: 631-6.
35. Schmidli RS, Colman PG, Bonifacio E and participating laboratories. Disease sensitivity and specificity of 52 assays for glutamic acid decarboxylase antibodies. The second international GAD Ab workshop. Diabetes 1995; 44:636-40.
36. Bottazzo GF, Dean BM, Gorsuch AN et al. Complement-fixing islet cell antibodies in type 1 diabetes: possible monitors of active beta-cell damage. Lancet 1980; 1:668-72.
37. Lernmark Å, Molenaar JL, van Beers WAM et al. The fourth international serum exchange workshop to standardize cytoplasmic islet cell antibodies. Diabetologia 1991; 34:534-5.
38. Palmer JP, Asplin CM, Clemons P et al. Insulin antibodies in insulin dependent diabetes before insulin treatment. Science 1983; 222: 1337-9.
39. Norazmi MN, Peakman M, Vergani D, Baum H. Shared amino acid sequences between glutamic acid decarboxylase 65 and 67 and alpha-2-macroglobulin. A focus for cross-reactive autoantibodies? Diabetologia 1995; 38:874-5.
40. Tian J, Lehmann PV, Kaufman DL. T cell cross-reactivity between coxsackievirus and glutamate decarboxylase is associated with a murine diabetes susceptibility allele. J Exp Med 1994; 180:1979-84.